What Is the Role of Rituximab in Nodular Lymphocyte-Predominant Hodgkin Lymphoma?

被引：0
作者：
Eichenauer, Dennis A. [1 ]
Engert, Andreas
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, DE-50937 Cologne, Germany
来源：
ACTA HAEMATOLOGICA | 2015年 / 134卷 / 03期
关键词：
STUDY-GROUP GHSG; PHASE-2;
D O I：
10.1159/000381765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：185 / 186
页数：2
相关论文
共 9 条
  • [1] Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Advani, Ranjana H.
    Horning, Sandra J.
    Hoppe, Richard T.
    Daadi, Sarah
    Allen, John
    Natkunam, Yasodha
    Bartlett, Nancy L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (09) : 912 - +
  • [2] Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Eichenauer, D. A.
    Engert, A.
    Andre, M.
    Federico, M.
    Illidge, T.
    Hutchings, M.
    Ladetto, M.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 : 70 - 75
  • [3] Management of nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Engert, Andreas
    [J]. HEMATOLOGICAL ONCOLOGY, 2013, 31 : 47 - 50
  • [4] Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Fuchs, Michael
    Pluetschow, Annette
    Klimm, Beate
    Halbsguth, Teresa
    Boell, Boris
    Von Tresckow, Bastian
    Nogova, Lucia
    Borchmann, Peter
    Engert, Andreas
    [J]. BLOOD, 2011, 118 (16) : 4363 - 4365
  • [5] Fanale MA., 2010, BLOOD, V116, P2812
  • [6] The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
    Hartmann, Sylvia
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Mottok, Anja
    Bob, Roshanak
    Koch, Karoline
    Bernd, Heinz-Wolfram
    Cogliatti, Sergio
    Hummel, Michael
    Feller, Alfred C.
    Ott, German
    Moeller, Peter
    Rosenwald, Andreas
    Stein, Harald
    Hansmann, Martin-Leo
    Engert, Andreas
    Klapper, Wolfram
    [J]. BLOOD, 2013, 122 (26) : 4246 - 4252
  • [7] High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    Karuturi, Meghan
    Hosing, Chitra
    Fanale, Michelle
    Medeiros, L. Jeffrey
    Alousi, Amin M.
    de Lima, Marcos J.
    Qazilbash, Muzaffar H.
    Kebriaei, Partow
    Younes, Anas
    Khouri, Issa
    Andersson, Borje S.
    Champlin, Richard
    Anderlini, Paolo
    Popat, Uday
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) : 991 - 994
  • [8] Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
    Mocikova, Heidi
    Pytlik, Robert
    Stepankova, Pavla
    Michalka, Jozef
    Markova, Jana
    Koren, Jan
    Buresova, Lucie
    Raida, Ludek
    Kral, Zdenek
    [J]. ACTA HAEMATOLOGICA, 2015, 134 (03) : 187 - 192
  • [9] Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma:: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
    Schulz, Holger
    Rehwald, Ute
    Morschhauser, Franck
    Elter, Thomas
    Driessen, Christoph
    Ruediger, Thomas
    Borchmann, Peter
    Schnell, Roland
    Diehl, Volker
    Engert, Andreas
    Reiser, Marcel
    [J]. BLOOD, 2008, 111 (01) : 109 - 111
1